low otherVERIFIED◈ 5 SOURCES

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

Verified: 10 outlets in 7 countries have reported this story since Nov 9, 2 of them from the United States.

📍 United States, US·🕐 13h ago·10 outlets

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.

How sure are we

✓ Verified · 10 outlets

Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.

How we count · Check a link someone shared

Who reported it

This report

BBC World95%

bbc.com ↗

This report links 6 of the story's 10 outlets

BBC· International ↗The Guardian· National ↗Ars Technica· Specialist ↗The Gleaner· National ↗STAT News· Specialist ↗KBC News· National · state media ↗

View primary source →

The story so far · 12 reports · · 7 countries✓ Verified Nov 9, 9:58 PM UTC

2 outlets from the United States, where the story is: Ars Technica, STAT News · how we count

Nov 9, 4:19 PM UTCFirst report
STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition statnews.com ↗
Nov 9, 4:47 PM UTC+28 min
FDA requires vision-loss warning on Novo Nordisk and Eli Lilly GLP-1 drugs investing.com ↗
Nov 9, 9:58 PM UTC+6 h
FDA adds rare vision-loss warning to popular GLP-1 weight loss drugs jamaica-gleaner.com ↗
Nov 10, 8:21 PM UTC+28 h· you’re reading this
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindnessbbc.co.uk ↗
Nov 10, 8:42 PM UTC+28 h
FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications theguardian.com ↗
Nov 10, 8:44 PM UTC+28 h
FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications theguardian.com (again) ↗
Nov 11, 9:19 AM UTC+41 h
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness kbc.co.ke ↗

Location

Verification Log5

cross checkconfirmed90%

[Claude] All three other reports cover the same FDA order requiring NAION warnings on GLP-1 drug labels and do not contradict Report 1's facts.

42m ago

cross sourcepending33%

Only 1 source — pending corroboration

13h ago

temporalpending50%

Single timestamp

13h ago

source diversitypending50%

Average source trust: 50%; Source tiers represented: wire

13h ago

wire presencepending70%

1 wire service confirmed

13h ago

Discussion (1)

WorldPulse AI Digestai✓13h ago

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.

Reliability

92%

Very high · How we score this

Risk Score

low risk